Weiwei Mu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Nanoplatforms for cancer theranostics 20
- Nanowire Synthesis and Applications 5
- Immunology 17
- Immunotherapy and Immune Responses 10
- Immune cells in cancer 6
- Immune Cell Function and Interaction 4
- Co-authors
- Na Zhang (32 shared papers)Yongjun Liu (25 shared papers)Qihui Chu (7 shared papers)Shuang Liang (20 shared papers)Shunli Fu (20 shared papers)Tong Gao (19 shared papers)Zipeng Zhang (17 shared papers)Dandan Jiang (5 shared papers)
- Journals
- ACS Applied Materials & Interfaces (5 papers)Advanced Science (4 papers)ACS Nano (4 papers)Nature Communications (2 papers)Biological Trace Element Research (2 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Weiwei Mu
49 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 101
- Biomaterials 328
- Immunology 283
- Biomedical Engineering 622
- Oncology 203
- Hepatology 44
Countries citing papers authored by Weiwei Mu
This map shows the geographic impact of Weiwei Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Mu more than expected).
Fields of papers citing papers by Weiwei Mu
This network shows the impact of papers produced by Weiwei Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Mu. The network helps show where Weiwei Mu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Mu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 272 | |
| 2 | 2023 | 64 | |
| 3 | 2019 | 64 | |
| 4 | 2016 | 61 | |
| 5 | 2020 | 52 | |
| 6 | 2013 | 47 | |
| 7 | 2020 | 46 | |
| 8 | 2024 | 42 | |
| 9 | 2011 | 40 | |
| 10 | 2018 | 40 | |
| 11 | 2021 | 38 | |
| 12 | 2021 | 32 | |
| 13 | 2023 | 32 | |
| 14 | 2015 | 31 | |
| 15 | 2020 | 29 | |
| 16 | 2021 | 27 | |
| 17 | 2024 | 26 | |
| 18 | 2016 | 26 | |
| 19 | 2021 | 21 | |
| 20 | 2014 | 19 |
About Weiwei Mu
Weiwei Mu is a scholar working on Biomedical Engineering, Immunology, Oncology, Molecular Biology and Materials Chemistry, having authored 50 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (20 papers), Immunotherapy and Immune Responses (10 papers), Silicon Nanostructures and Photoluminescence (8 papers), Nanoparticle-Based Drug Delivery (8 papers), Immune cells in cancer (6 papers), Nanowire Synthesis and Applications (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Biomaterials (328 citations), Immunology (283 citations), Biomedical Engineering (622 citations), Oncology (203 citations) and Hepatology (44 citations). Weiwei Mu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Na Zhang, Yongjun Liu, Qihui Chu, Shuang Liang, Shunli Fu, Tong Gao, Zipeng Zhang, Dandan Jiang, Kunji Chen and Jun Xu. Their work appears in journals such as ACS Applied Materials & Interfaces, Advanced Science, ACS Nano, Nature Communications and Biological Trace Element Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.